A Phase II, Double Blind, Placebo-controlled, Randominzed, Multi-Center, Parallel Group Study to Evaluate the Efficacy and Safety of T89 in Patient With Chronic Stable Angina Pectoris
Latest Information Update: 14 Jan 2020
At a glance
- Drugs T 89 (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- 13 Oct 2011 New trial record